Pinnacle West Capital Corporation: Truist Securities cuts target price to $101 from $107
PNW•Related News
Can-Fite plans Phase IIb trial of namodenoson plus gemcitabine in advanced pancreatic cancer
CANF•
V2X Chief Growth Officer Roger Mason confirmed as NRO director
VVX•
ITG Inc: Morgan Stanley cuts target price to $18.00 from $19.00
ITG•
VinFast plans phased upgrade to L2+/L2++ driver-assistance systems, ties rollout to safety validation
VFS•
Newmont <NEM.N>: BofA Global Research Raises Price Objective to $145 From $135
NEM•